The United States Department of Justice sends this information as posted below:
OKLAHOMA CITY – Edward Shadid, MD (“Dr. Shadid”), paid $110,000 to settle civil penalty claims stemming from allegations that he violated the Comprehensive Drug Abuse Prevention and Control Act of 1970 (“Act”) and its regulations, announced U.S. Attorney Robert J. Troester.
Recordkeeping is a vital part of managing controlled substances. Complete and accurate records help avoid diversions and losses of controlled drugs. A Drug Enforcement Administration (“DEA”) registrant who transfers controlled substances between locations must comply with the applicable requirements as well as register with the DEA for each principal place of business or professional practice where controlled substances are stored. Registrants must also follow the inventory requirements when purchasing and storing controlled substances. Failure to do so subjects the registrant to civil monetary penalties.
Dr. Shadid is a board-certified spinal surgeon who operates the Spine & Pain Care of Oklahoma clinic in Edmond, Oklahoma (“Spine & Pain Edmond”) and the Spine & Pain Care of Oklahoma clinic in Lawton, Oklahoma (“Spine & Pain Lawton”). The United States alleges that from January 2024 through July 2025, Dr. Shadid failed to use DEA Form 222s when transferring Schedule II controlled substances from Spine & Pain Edmond to Spine & Pain Lawton. Dr. Shadid also failed to maintain accurate records of transfers of Schedule IV controlled substances between the same clinic locations. In addition, Dr. Shadid failed to obtain a separate DEA registration for Spine & Pain Lawton and maintain a biennial inventory of the controlled substances stored at the clinics. To resolve these allegations, Dr. Shadid agreed to pay $110,000 to the United States.
In reaching this settlement, Dr. Shadid did not admit liability, and the government did not make any concessions about the legitimacy of the claims. The
agreement allows the parties to avoid the delay, expense, inconvenience, and uncertainty involved in litigating the case.
This case was investigated by the Drug Enforcement Administration, Office of Diversion Control. Assistant U.S. Attorneys Ronald R. Gallegos and Amanda R. Johnson prosecuted the case.
Free Press curates press releases from organizations and people we know to be reputable. If you would like to submit a well-written press release for us to publish on our site, please click the email icon at the top of this page.
